Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .
This 389th consecutive quarterly dividend will be paid on 17 May 2021 to shareholders of record at the close of business on 15 April 2021.
Also, the company said it has paid dividends since 1924 and increased its dividend payout for 49 consecutive years.
Abbott discovers, develops, manufactures and sells health care products worldwide. It operates through the Established Pharmaceutical Products segment; Diagnostic Products segment; and Medical Devices segment. It has an agreement with Tandem Diabetes Care to develop and commercialise integrated diabetes solutions.
The company was founded in 1888 and is headquartered in North Chicago, Illinois, USA.
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Lilly declares Q3 2026 dividend
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100